1887

n Cardiovascular Journal of South Africa - Lipitor reduces total cardiovascular events in patients with type 2 diabetes : drug trends in cardiology

USD

 

Abstract

Extracted from text ... Lipitor reduces total cardiovascular events in patients with type 2 diabetes Patients with type 2 diabetes taking Pfizer's cholesterol-lowering medicine Lipitor(r) (atorvastatin calcium) had a clinically relevant reduction in the incidence of cardiovascular events, according to results of a subgroup analysis of patients with type 2 diabetes from the three-year Anglo-Scandinavian Cardiac Outcomes Trial: Lipid-Lowering Arm (ASCOT-LLA), presented at the American College of Cardiology recently. The data are from 2 532 study subjects with type 2 diabetes, high blood pressure and high cholesterol, who showed a 23% reduction in the number of total cardiovascular events, such as a heart attack or ..

Loading

Article metrics loading...

/content/cardio/15/3/EJC23907
2004-05-01
2016-12-02
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error